Tamoxifen-induced hypercalcemia in metastatic breast cancer.
作者信息
Nemoto T, Rosner D H, Patel D J, Wettingfeld R F, Bambrah S S, Dao T L
出版信息
N Y State J Med. 1980 Dec;80(13):1980-2.
PMID:6937756
Abstract
摘要
相似文献
1
Tamoxifen-induced hypercalcemia in metastatic breast cancer.他莫昔芬诱发的转移性乳腺癌高钙血症。
N Y State J Med. 1980 Dec;80(13):1980-2.
2
Hypercalcemia induced by tamoxifen.他莫昔芬诱导的高钙血症。
Am J Surg. 1981 Feb;141(2):277-8. doi: 10.1016/0002-9610(81)90174-4.
3
Tamoxifen-related vasculitis.他莫昔芬相关的血管炎。
J Clin Oncol. 2006 Jul 20;24(21):3504-5. doi: 10.1200/JCO.2005.05.3322.
4
Tamoxifen-induced hypercalcemia in breast cancer.他莫昔芬诱导的乳腺癌高钙血症。
Cancer. 1981 Jun 15;47(12):2803-6. doi: 10.1002/1097-0142(19810615)47:12<2803::aid-cncr2820471208>3.0.co;2-a.
5
Tamoxifen and hypercalcaemia.他莫昔芬与高钙血症
Br J Clin Pract. 1992 Summer;46(2):80.
6
Tamoxifen and estrogen hypercalcemia.他莫昔芬与雌激素性高钙血症
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2124-5.
7
Tamoxifen and life-threatening hypercalcaemia.他莫昔芬与危及生命的高钙血症。
Lancet. 1979 Aug 25;2(8139):413-4. doi: 10.1016/s0140-6736(79)90423-9.
8
Tamoxifen in the treatment of osseous metastatic breast cancer. A case report.他莫昔芬治疗骨转移性乳腺癌。病例报告。
J Med Assoc Thai. 1984 Mar;67(3):188-93.
9
Safety of tamoxifen.他莫昔芬的安全性。
Lancet. 1978 Feb 18;1(8060):396-7. doi: 10.1016/s0140-6736(78)91127-3.
引用本文的文献
1
Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.原发性干燥综合征患者自然杀伤细胞细胞毒性因子释放受损。
Clin Exp Immunol. 1988 May;72(2):299-302.
Zotero 插件